Workflow
WSJ
icon
Search documents
Europe's Exports to U.S. Rose Despite Tariffs, as Imports From China Jumped
WSJ· 2026-02-13 10:47
Core Insights - The EU's exports to the U.S. remained stable last year despite the tariffs imposed by the Trump administration [1] - Increased duties led Chinese businesses to seek new customers within the EU [1] Summary by Categories Trade Dynamics - EU exports to the U.S. were resilient in the face of tariffs [1] - Chinese companies are adapting to the tariff environment by targeting the EU market for new business opportunities [1]
Global Markets, U.S. Futures Fall as Market Watches for Inflation Print to Close out Rocky Week
WSJ· 2026-02-13 09:59
Core Viewpoint - U.S. equities are expected to continue their downward trend due to renewed concerns over competition in the AI sector, despite some optimism stemming from a U.S.-Taiwan trade deal and reports of reduced trade restrictions with China [1] Group 1: AI Competition Concerns - Fresh concerns regarding competition in the AI industry are impacting U.S. equities, suggesting a potential for further losses in the market [1] Group 2: Trade Developments - A trade deal between the U.S. and Taiwan is seen as a positive development that could provide a catalyst for market recovery [1] - Reports indicating easing trade restrictions with China are contributing to hopes for improved trade relations and potential market stabilization [1]
L'Oreal's Shares Drop After Soft End to the Year
WSJ· 2026-02-13 09:47
Core Insights - The cosmetics giant reported weaker-than-expected results for the previous year, indicating challenges in navigating a complex beauty market landscape [1] Company Performance - The company's financial performance fell short of market expectations, reflecting difficulties in adapting to changing consumer preferences and competitive pressures [1] Market Landscape - The beauty market is described as complex, suggesting a variety of factors influencing consumer behavior and market dynamics, which may have contributed to the company's underperformance [1]
Ubisoft Shares Jump on Cash Forecast
WSJ· 2026-02-13 09:47
Core Viewpoint - Ubisoft Entertainment has assured investors that it has sufficient cash to meet upcoming debt maturities while undergoing a significant overhaul of its operations and gaming portfolio [1] Company Summary - Ubisoft is currently in the process of restructuring its operations and gaming portfolio to enhance its market position and financial stability [1]
Stock Market Today: Dow Futures Fall Ahead of Inflation Report
WSJ· 2026-02-13 08:48
Core Viewpoint - The consumer-price index for January is expected to be released, which will provide insights into inflation trends and economic conditions [1] Group 1 - The release of the consumer-price index is anticipated to influence market expectations regarding interest rates and monetary policy [1] - Analysts are closely monitoring the index as it may indicate shifts in consumer spending and overall economic health [1]
Swiss Inflation Holds Steady
WSJ· 2026-02-13 08:02
Core Viewpoint - The article indicates that the Swiss National Bank is expected to maintain its current interest rates during the upcoming meeting [1] Summary by Relevant Categories - **Monetary Policy Expectations** - The reading supports the anticipation that the Swiss National Bank will keep rates unchanged at its next meeting [1]
NatWest Sets Out Performance Targets After Quarterly Beat
WSJ· 2026-02-13 07:55
Core Viewpoint - NatWest has projected further income growth and profitability for the year following fourth-quarter results that exceeded expectations [1] Group 1: Financial Performance - The fourth-quarter results reported by NatWest surpassed market expectations, indicating strong financial performance [1] - The company is optimistic about its income growth and profitability for the upcoming year, suggesting a positive outlook for its financial health [1]
Novartis Says Vanrafia Drug Slows Kidney Function Decline
WSJ· 2026-02-13 06:57
Core Insights - The pharmaceutical company announced that phase 3 trials demonstrated that Vanrafia effectively slowed the decline in kidney function for adults suffering from progressive autoimmune kidney disease, specifically IgA nephropathy [1] Group 1 - The phase 3 trials indicate a positive outcome for Vanrafia in treating IgA nephropathy [1] - The drug targets a specific demographic, namely adults with progressive autoimmune kidney disease [1] - The results may position the company favorably in the competitive landscape of kidney disease treatments [1]
Capgemini Expects AI Demand to Fuel Growth in Year Ahead
WSJ· 2026-02-13 06:30
Core Viewpoint - Capgemini anticipates that demand related to artificial intelligence will drive growth in 2026, following an increase in orders attributed to AI services in the last quarter of the previous year [1] Group 1 - The company reported a significant uplift in orders during the final quarter of last year, which was primarily driven by AI services [1]
Safran Lifts 2028 Outlook On Strong Civil Engines Aftermarket, Defense Demand
WSJ· 2026-02-13 06:23
Group 1 - Safran has increased its 2028 forecasts due to strong performance in the civil engines aftermarket, which includes maintenance and repairs [1] - The company is also experiencing growing demand in the defense sector, contributing to its optimistic outlook [1]